Cargando…

Identification of Gene-Tyrosine Kinase 2 (TYK2) in Head and Neck Squamous Cell Carcinoma Patients—An Integrated Bioinformatics Approach

BACKGROUND: The human tyrosine kinase 2 (TYK2) has been found to be associated with at least 20 autoimmune diseases; however, its tumor-regulating role in head and neck squamous cell carcinoma (HNSC) has not been researched by using an integrative bioinformatics approach, yet. OBJECTIVE: To investig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gong, Xiaoyan, Ren, Fukai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197628/ https://www.ncbi.nlm.nih.gov/pubmed/35711568 http://dx.doi.org/10.1155/2022/5239033

Ejemplares similares

Retracted: Identification of Gene-Tyrosine Kinase 2 (TYK2) in Head and Neck Squamous Cell Carcinoma Patients—An Integrated Bioinformatics Approach
por: Markers, Disease
Publicado: (2023)

TYK2 correlates with immune infiltration: A prognostic marker for head and neck squamous cell carcinoma
por: He, Yaodong, et al.
Publicado: (2022)

In vivo tumor surveillance by NK cells requires TYK2 but not TYK2 kinase activity
por: Prchal-Murphy, Michaela, et al.
Publicado: (2015)

TYK2: An Upstream Kinase of STATs in Cancer
por: Wöss, Katharina, et al.
Publicado: (2019)

Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods
por: Jin, Yu, et al.
Publicado: (2019)

An integrated bioinformatics analysis of the S100 in head and neck squamous cell carcinoma
por: Bai, Guo, et al.
Publicado: (2023)

Tyrosine kinase domain mutations of EGFR gene in head and neck squamous cell carcinoma
por: Vatte, Chittibabu, et al.
Publicado: (2017)

Identification of Hub Genes Associated With Development of Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatics Analysis
por: Li, Chia Ying, et al.
Publicado: (2020)

Oncogenic TYK2 P760L kinase is effectively targeted by combinatorial TYK2, mTOR and CDK4/6 kinase blockade
por: Woess, Katharina, et al.
Publicado: (2022)

Novel Small Molecule Tyrosine Kinase 2 Pseudokinase Ligands Block Cytokine-Induced TYK2-Mediated Signaling Pathways
por: Zhou, Yu, et al.
Publicado: (2022)

Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas
por: Lüttich, Lina, et al.
Publicado: (2021)

Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL- 12
Publicado: (1995)

TYK2 in Tumor Immunosurveillance
por: Karjalainen, Anzhelika, et al.
Publicado: (2020)

A novel highly selective allosteric inhibitor of tyrosine kinase 2 (TYK2) can block inflammation- and autoimmune-related pathways
por: Chen, Celia X.-J., et al.
Publicado: (2023)

Clinical value of monoclonal antibodies and tyrosine kinase inhibitors in the treatment of head and neck squamous cell carcinoma
por: Blaszczak, Wiktoria, et al.
Publicado: (2017)

Two common disease-associated TYK2 variants impact exon splicing and TYK2 dosage
por: Li, Zhi, et al.
Publicado: (2020)

Transcriptome analysis reveals a major impact of JAK protein tyrosine kinase 2 (Tyk2) on the expression of interferon-responsive and metabolic genes
por: Vogl, Claus, et al.
Publicado: (2010)

Prognostic values and clinical relationship of TYK2 in laryngeal squamous cell cancer
por: Fang, Lucheng, et al.
Publicado: (2021)

Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis
por: Yang, Ke, et al.
Publicado: (2019)

Ron tyrosine kinase receptor synergises with EGFR to confer adverse features in head and neck squamous cell carcinoma
por: Keller, J, et al.
Publicado: (2013)

A comparative proteome analysis links tyrosine kinase 2 (Tyk2) to the regulation of cellular glucose and lipid metabolism in response to poly(I:C)
por: Grunert, Tom, et al.
Publicado: (2011)

Subtyping of Type 1 Diabetes as Classified by Anti-GAD Antibody, IgE Levels, and Tyrosine kinase 2 (TYK2) Promoter Variant in the Japanese
por: Mine, Keiichiro, et al.
Publicado: (2017)

Identification of potential therapeutic target genes and mechanisms in head and neck squamous cell carcinoma by bioinformatics analysis
por: KUANG, JING, et al.
Publicado: (2016)

Identification of potential biomarkers and analysis of prognostic values in head and neck squamous cell carcinoma by bioinformatics analysis
por: Yang, Bo, et al.
Publicado: (2017)

Integrative Analysis of TP53INP2 in Head and Neck Squamous Cell Carcinoma
por: Cao, Ruoyan, et al.
Publicado: (2021)

TYK2 Kinase Activity Is Required for Functional Type I Interferon Responses In Vivo
por: Prchal-Murphy, Michaela, et al.
Publicado: (2012)

TYK2 in Immune Responses and Treatment of Psoriasis
por: Shang, Lin, et al.
Publicado: (2022)

Bioinformatics-based discovery of PYGM and TNNC2 as potential biomarkers of head and neck squamous cell carcinoma
por: Jin, Yu, et al.
Publicado: (2019)

Expression and prognostic potential of PLEK2 in head and neck squamous cell carcinoma based on bioinformatics analysis
por: Wang, Jingyun, et al.
Publicado: (2021)

Receptor-Tyrosine-Kinase-Targeted Therapies for Head and Neck Cancer
por: Elferink, Lisa A., et al.
Publicado: (2011)

HOTTIP Functions as a Key Candidate Biomarker in Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatic Analysis
por: Yin, Xiteng, et al.
Publicado: (2019)

Identification and Analysis of Senescence-Related Genes in Head and Neck Squamous Cell Carcinoma by a Comprehensive Bioinformatics Approach
por: Deng, Lin, et al.
Publicado: (2022)

Identification of HOXB9 based on comprehensive bioinformatics analysis for predicting prognosis of head and neck squamous cell carcinoma
por: Li, Juanjuan, et al.
Publicado: (2023)

Acquired resistance to EGFR tyrosine kinase inhibitors alters the metabolism of human head and neck squamous carcinoma cells and xenograft tumours
por: Beloueche-Babari, M, et al.
Publicado: (2015)

TYK2 Promoter Variant and Diabetes Mellitus in the Japanese
por: Nagafuchi, Seiho, et al.
Publicado: (2015)

TYK2 Variants in B-Acute Lymphoblastic Leukaemia
por: Turrubiartes-Martínez, Edgar, et al.
Publicado: (2020)

TYK2 in Cancer Metastases: Genomic and Proteomic Discovery
por: Borcherding, Dana C., et al.
Publicado: (2021)

Tyk2 is a tumor suppressor in colorectal cancer
por: Moritsch, Stefan, et al.
Publicado: (2022)

Tyk2 Targeting in Immune-Mediated Inflammatory Diseases
por: Rusiñol, Lluís, et al.
Publicado: (2023)

LINC00958 and HOXC13-AS as key candidate biomarkers in head and neck squamous cell carcinoma by integrated bioinformatics analysis
por: Xiong, Dan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p8npfvlqi166981e1g993mgv1g